News
Abbott’s diet drug study renews calls for U.S. ban (Reuters)
September 2, 2010 by publisher · Leave a Comment
Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
Original post:
Abbott’s diet drug study renews calls for U.S. ban
(Reuters)

